Last month, Pennsylvania Physician General Dr. Denise Johnson expanded the state’s standing order prescription for naloxone nasal spray to include a nasal spray with a higher dose of the opioid antagonist. While a March 23 press release from the Wolf Administration frames the move as an “expansion” of the state’s naloxone provision to prevent fatal opioid overdoses, the overdose prevention experts at Prevention Point Pittsburgh question whether this is the most effective move to increase access to the life-saving drug.…